フロリダ州における皮膚筋炎の臨床試験
フロリダ州内の拠点で、皮膚筋炎に関する7件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Boca Raton
- Research Site, Margate
- Research Site, Miami
- 他3件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06455449RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic Florida - Accepting Adult Patients, Jacksonville
- Johns Hopkins All Children's Hospital - Accepting Juvenile Patients, St. Petersburg
被験者募集中第2/3相
6歳〜75歳 · 全性別 · 2026/09/17更新 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
- University of Miami Dermatology Clinical Trials Unit, Miami
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Jacksonville
被験者募集中第1相
18歳〜74歳 · 全性別 · 2026/09/10更新 · NCT07085104Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- University of Miami Hospital and Clinics, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07486869Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
- Malcom Randall North Florida/South Georgia VA Medical Center, Gainesville
- Bioresearch Partner, Miami
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/27更新 · NCT07160205Rheumatology Diet Study
- UCF Health Clinics, Orlando
被験者募集中観察研究
18歳〜65歳 · 全性別 · 2024/12/06更新 · NCT06339957ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。